Oral administration of Limosilactobacillus reuteri VHProbi® M07 alleviates ovalbumin-induced allergic asthma in mice
Oral administration of M07 mitigated key features of inflammatory responses in the OVA-induced mice asthma model. These findings suggest that M07 holds therapeutic potential for the treatment of allergic asthma.
Authors
- Lei Song (ORCID: https://orcid.org/0000-0002-4115-065X)
- Chaoqun Guo (ORCID: https://orcid.org/0000-0002-1626-1024)
- Zhi Duan (ORCID: https://orcid.org/0000-0001-6856-0002)
- Hongchang Cui (ORCID: https://orcid.org/0000-0002-5626-1213)
- Guoqing Meng
- Congrui Feng
Institutions
- Heze University (CN)
- Ocean University of China (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1371/journal.pone.0317587
- Citations
- 1
- Primary Topic
- Probiotics and Fermented Foods
- Type
- article
- Field-Weighted Citation Impact
- 1.16